Patients with hypogonadism have increased health care costs

Nelson Vergel

Founder, ExcelMale.com
This retrospective study from a commercial US health plan describes a population of more than 5,000 men with newly diagnosed primary or secondary hypogonadism. We found that patients with primary and secondary hypogonadism had increased health care utilization and cost during the year after their diagnosis compared with matched controls without diagnosed hypogonadism but with a similar baseline comorbidity burden.

These results are consistent with those of a previous study using retrospective data, also in the United States, but from a different source.11 Kaltenboeck et al11 examined a prevalent, rather than incident, hypogonadism cohort (including primary, secondary, and age-related etiologies) and used risk adjustment rather than direct matching to estimate control group costs. Annual risk-adjusted all-cause direct costs in that study were $9,291 for hypogonadism (any type) vs $5,248 for non-hypogonadism controls.

Further research is necessary to determine how primary and secondary hypogonadism contributes to increased health care costs over time. The constellation of symptoms observed in patients with hypogonadism—decreased energy, loss of muscle, depressed mood, fractures, and frailty—can lead to physical inactivity and aggravate the attendant risk of diabetes and cardiovascular disease. This study was limited to 1 year of follow-up after hypogonadism diagnosis, so a full picture of the economic burden of hypogonadism might require longer observation. More research also is needed to investigate the potential benefit of TRT in mitigating the burden of hypogonadism.

http://www.jsm.jsexmed.org/article/S1743-6095(16)30483-0/fulltext
 
Last edited:
Hey Nelson, either you made a typo with the title, or I am massively misunderstanding this study.

It seems as if the study is suggesting that people with newly diagnosed and treated hypogonadism have an increased usage of healthcare in the year following their diagnosis compared to those without newly diagnosed hypogonadism.

It strikes me as rather obvious, that one with a newly diagnosed medical condition would use more healthcare.

[FONT=&quot] Outpatient visits and pharmacy costs were the largest contributors to total cost and to cost increases. Approximately 15% of total costs, primarily outpatient and pharmacy costs, were identifiable as related to hypogonadism


The study even explains that the money is mostly at out patient doctor's visits and pharmacies. Duh!

I must be missing something huge here haha. [/FONT]
 
Before I was being treated I had a pretty good medical record of complaining about this/that/the other, I kept saying to my MD "me wellness is terrible", just so nonspecific all I could say is I don't fell "well" I agree that untreated was having me in the Drs office much more than I am now.
 
Hey Nelson, either you made a typo with the title, or I am massively misunderstanding this study.

It seems as if the study is suggesting that people with newly diagnosed and treated hypogonadism have an increased usage of healthcare in the year following their diagnosis compared to those without newly diagnosed hypogonadism.

It strikes me as rather obvious, that one with a newly diagnosed medical condition would use more healthcare.



The study even explains that the money is mostly at out patient doctor's visits and pharmacies. Duh!

I must be missing something huge here haha. [/FONT][/COLOR]

You are right!
 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

TRT Hormone Predictor Widget

TRT Hormone Predictor

Predict estradiol, DHT, and free testosterone levels based on total testosterone

⚠️ Medical Disclaimer

This tool provides predictions based on statistical models and should NOT replace professional medical advice. Always consult with your healthcare provider before making any changes to your TRT protocol.

ℹ️ Input Parameters

Normal range: 300-1000 ng/dL

Predicted Hormone Levels

Enter your total testosterone value to see predictions

Results will appear here after calculation

Understanding Your Hormones

Estradiol (E2)

A form of estrogen produced from testosterone. Important for bone health, mood, and libido. Too high can cause side effects; too low can affect well-being.

DHT

Dihydrotestosterone is a potent androgen derived from testosterone. Affects hair growth, prostate health, and masculinization effects.

Free Testosterone

The biologically active form of testosterone not bound to proteins. Directly available for cellular uptake and biological effects.

Scientific Reference

Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, Singh AB, LaValley MP, Mazer NA, Bhasin S. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64.

DOI: 10.1210/jc.2010-0102 | PMID: 20534765 | PMCID: PMC2913038

Beyond Testosterone Podcast

Online statistics

Members online
2
Guests online
372
Total visitors
374

Latest posts

Back
Top